A tactical nanomissile mobilizing antitumor immunity enables neoadjuvant chemo-immunotherapy to minimize postsurgical tumor metastasis and recurrence

Neoadjuvant chemotherapy has become an indispensable weapon against high-risk resectable cancers, which benefits from tumor downstaging. However, the utility of chemotherapeutics alone as a neoadjuvant agent is incapable of generating durable therapeutic benefits to prevent postsurgical tumor metast...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Tao, Hu, Mingxing, Zhu, Shunyao, Shen, Meiling, Kou, Xiaorong, Liang, Xiuqi, Li, Lu, Li, Xinchao, Zhang, Miaomiao, Wu, Qinjie, Gong, Changyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979264/
https://www.ncbi.nlm.nih.gov/pubmed/36873172
http://dx.doi.org/10.1016/j.apsb.2022.09.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979264/
https://www.ncbi.nlm.nih.gov/pubmed/36873172
http://dx.doi.org/10.1016/j.apsb.2022.09.017

Ejemplares similares